Monday, January 12, 2026
DD India
March 20, 2025 3:50 PM
Global pharmaceutical company Eli Lilly has launched Mounjaro (tirzepatide) in India, a groundbreaking drug designed for the treatment of Type 2 diabetes and obesity. Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro is n...
August 1, 2024 5:26 PM
Trial results show Eli Lilly's weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure, the company said on Thursday as it continues to build a case for the medicati...
July 9, 2024 4:57 PM
Shares in Novo Nordisk, maker of the wildly popular obesity drug Wegovy were down 1.1% on Tuesday after the publication of a data analysis showing rival Eli Lilly's own treatment Mounjaro leads to faster and greater weight loss. The analysis was pub...
Copyright © 2026 DD India. All rights reserved
Visitors: 7,231,939
Last updated on: 11th January 2026
